Msquare Medical Technology (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -32.96%
- Profit Growth -226.55%
- Ebitda -150.38%
- Net Worth -40.16%
- Total Assets -8.66%
About Msquare Medical Technology (Opc)
Msquare Medical Technology (Opc) Private Limited (MMTOPL) is a Company incorporated in India on 24 January 2018 (Seven years and one month 3 days old ). Its registered office is in Madurai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ramanujam Ramanujam serves as a director at the Company.
Company Details
- Location
Madurai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33300TN2018OPC120646
- Company No.
120646
- Incorporation Date
24 Jan 2018
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Healthcare
What products or services does Msquare Medical Technology (Opc) Private Limited offer?
Msquare Medical Technology (Opc) Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Surgical & ICU Equipments, Ventilator Parts & Consumables, Surgical & Medical Consumables, Surgical Disposables, Industrial & Engineering Goods, Precision Rods, Forceps & Graspers, Surgical Clamps.
Who are the key members and board of directors at Msquare Medical Technology (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramanujam Ramanujam  | Director | 24-Jan-2018 | Current |
Financial Performance of Msquare Medical Technology (Opc).
Msquare Medical Technology (Opc) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.96% decrease. The company also saw a substantial fall in profitability, with a 226.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Msquare Medical Technology (Opc)?
In 2023, Msquare Medical Technology (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Msquare Medical Technology (Opc)?
Unlock and access historical data on people associated with Msquare Medical Technology (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Msquare Medical Technology (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msquare Medical Technology (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.